CA057-003

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

What will happen during the trial?

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1/2
Enrollment
260 patients (estimated)
Tags
Cereblon E3 Ligase Modulators (CELMoDs)
Trial Type
Treatment
Last Update
SparkCures ID
1319
NCT Identifier
NCT05372354

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.